Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
edgeX: EDGE’s abnormal fluctuations are due to external manipulation and are not a platform security incident

edgeX: EDGE’s abnormal fluctuations are due to external manipulation and are not a platform security incident

Odaily星球日报Odaily星球日报2026/06/02 01:31
Show original

Odaily reported that edgeX released its latest statement regarding the abnormal price fluctuations of the EDGE token, stating that the protocol has not suffered any form of attack. The incident was not caused by hacking, vulnerability exploitation, or security flaws.

edgeX indicated that the information obtained so far shows that the abnormal fluctuation was the result of deliberate manipulation of the EDGE market price by some external participants. This is a matter of market integrity, not platform security.

The team stated they are actively investigating the incident with relevant exchanges and partner platforms, and will publish a more comprehensive incident report once the investigation is completed.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny